Literature DB >> 9464644

Tumor necrosis factor alpha augments amyloid beta protein (25-35) induced apoptosis in human cells.

I Blasko1, T L Schmitt, E Steiner, K Trieb, B Grubeck-Loebenstein.   

Abstract

No information is yet available on the effect of tumor necrosis factor alpha (TNFalpha) on amyloid beta protein (Abeta)-induced cytotoxicity in human cells. For this reason the induction of apoptosis by TNFalpha and Abeta (25-35) was studied in primary cultures of human thyroid and kidney cells as well as in the neuroblastoma line SK-N-SH and in DU-145 cells. Apoptosis occurred in all cell types after Abeta (25-35) treatment, but was markedly enhanced when TNFalpha was additionally present. This effect was less pronounced in transformed cell lines than in primary cultures, in which TNFalpha on its own was not cytotoxic. Apoptosis was still more prevalent under serum free culture conditions. The results demonstrate that TNFalpha may support the occurrence of Abeta-mediated cell death and thus contribute to the development of pathological changes in Alzheimer's disease (AD).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9464644     DOI: 10.1016/s0304-3940(97)00845-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Dysregulation of T-cell function in the elderly : scientific basis and clinical implications.

Authors:  Tamas Fulop; Anis Larbi; Anders Wikby; Eugenio Mocchegiani; Katsuiku Hirokawa; Graham Pawelec
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons.

Authors:  Giovanni Almanzar; Susanne Schwaiger; Brigitte Jenewein; Michael Keller; Dietmar Herndler-Brandstetter; Reinhard Würzner; Diether Schönitzer; Beatrix Grubeck-Loebenstein
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 3.  Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases.

Authors:  I Kadiu; J G Glanzer; J Kipnis; H E Gendelman; M P Thomas
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

4.  Etanercept therapy in patients with advanced primary amyloidosis.

Authors:  M A Hussein; J V Juturi; L Rybicki; S Lutton; B R Murphy; M A Karam
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

5.  Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease.

Authors:  Fiona E McAlpine; Malú G Tansey
Journal:  J Inflamm Res       Date:  2008-11-06

6.  Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines.

Authors:  Giovanni Perini; Vittorina Della-Bianca; Valeria Politi; Giuliano Della Valle; Ilaria Dal-Pra; Filippo Rossi; Ubaldo Armato
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

7.  Individual Cytokines Modulate the Neurological Symptoms of ATM Deficiency in a Region Specific Manner

Authors:  Chin Wai Hui; Karl Herrup
Journal:  eNeuro       Date:  2015-08-18

8.  Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders.

Authors:  Bitna Yi; Alam Jahangir; Andrew K Evans; Denise Briggs; Kristine Ravina; Jacqueline Ernest; Amir B Farimani; Wenchao Sun; Jayakumar Rajadas; Michael Green; Evan N Feinberg; Vijay S Pande; Mehrdad Shamloo
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

9.  CSF TNF-α Levels Were Associated with Longitudinal Change in Brain Glucose Metabolism Among Non-Demented Older People.

Authors:  Pan Fu; Bihong Zhu; Yangping Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-26       Impact factor: 2.570

10.  Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.

Authors:  Jiunn-Tay Lee; Jan Xu; Jin-Moo Lee; Grace Ku; Xianlin Han; Ding-I Yang; Shawei Chen; Chung Y Hsu
Journal:  J Cell Biol       Date:  2004-01-05       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.